Friday, February 22, 2019
iSchemaView, the world leader in advanced AVC imaging, has received approval from ANVISA (National Health Agency) for the use of the RAPID imaging platform across Brazil. RAPID is designed to provide physicians with fast, fully automated, elegant and easy-to-interpret images that facilitate clinical decision-making around stroke. The approval came after iSchemaView's quality system certification by the MDSAP (Medical Device Single Audit Program) - a comprehensive approach to auditing and monitoring the manufacture of medical devices in an effort to improve safety and oversight on an international scale.
Hospitals and clinics treating patients with ischemic stroke in Brazil will now have access to RAPID and its automated perfusion solutions by CT, MRI, Angio-tomography (Angio-CT) and ASPECTS. The expansion of RAPID in Brazil represents a significant market growth in South America and is another sign that RAPID has become the international standard of stroke images.
"RAPID demonstrates the tremendous leaps that medical technology has made over the last two years to improve the diagnosis and treatment of stroke patients," said Dr. Francisco Mont'Alverne, MD, PhD, Director of Interventional Neuro-radiology at General Hospital from Fortaleza. "This ANVISA approval means that hundreds of thousands of Brazilians can now benefit from RAPID's advanced artificial intelligence (AI) imaging technology."
Developed by leading AVC experts, the RAPID platform combines artificial intelligence capabilities with deep learning, machine learning, and advanced resource extraction. Together, they provide unparalleled sensitivity and specificity across all RAPID stroke modules (CT perfusion, MRI diffusion and perfusion, Angio-CT and TC ASPECT with automated scoring). The results, delivered by RAPID's intelligence services platform, can be viewed through PACS, email, text message, the RAPID application, or corporate partner workflow systems.
"Patients often arrive at the hospital several hours after the onset of stroke symptoms," said Dr. Fabricio Oliveira Lima, MD, PhD, PhD, chief of the Cerebrovascular Diseases Unit at Fortaleza General Hospital. "RAPID allows us to see the physiological state of the brain by the time the patient arrives and allows us to quickly identify those patients who are eligible for clot removal up to 24 hours after the onset of stroke. This increases the chances of recovery for our patients, reduces disability and saves lives. "
